MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328AA8. A total of 16 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $3,965,000 | -24.2% | 3,500,000 | 0.0% | 1.77% | -25.8% |
| Q1 2016 | $5,233,000 | +4.1% | 3,500,000 | 0.0% | 2.38% | +19.4% |
| Q4 2015 | $5,027,000 | -4.4% | 3,500,000 | 0.0% | 2.00% | +2.9% |
| Q3 2015 | $5,259,000 | -28.2% | 3,500,000 | 0.0% | 1.94% | -12.8% |
| Q2 2015 | $7,328,000 | -34.3% | 3,500,000 | -36.4% | 2.22% | -62.5% |
| Q1 2015 | $11,154,000 | +9.1% | 5,500,000 | 0.0% | 5.93% | +5.8% |
| Q4 2014 | $10,225,000 | +20.4% | 5,500,000 | 0.0% | 5.61% | +27.4% |
| Q3 2014 | $8,496,000 | +13.4% | 5,500,000 | 0.0% | 4.40% | +26.9% |
| Q2 2014 | $7,490,000 | – | 5,500,000 | – | 3.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 16,490,000 | $25,947,000 | 12.49% |
| SILVERBACK ASSET MANAGEMENT LLC | 14,500,000 | $22,711,000 | 2.37% |
| TANG CAPITAL MANAGEMENT LLC | 3,500,000 | $5,259,000 | 1.94% |
| ARISTEIA CAPITAL, L.L.C. | 11,932,000 | $18,727,000 | 0.95% |
| WOLVERINE ASSET MANAGEMENT LLC | 12,600,000 | $19,576,000 | 0.46% |
| Polar Capital LLP | 3,120,000 | $4,965,000 | 0.10% |
| Tekla Capital Management LLC | 1,485,000 | $2,336,000 | 0.08% |
| MIZUHO SECURITIES USA LLC | 194,000 | $305,000 | 0.08% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,410,000 | $2,206,000 | 0.06% |
| LAZARD ASSET MANAGEMENT LLC | 11,010,000 | $17,375,000 | 0.04% |